| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/10/2009 | US20090227016 Il-17 homologous polypeptides and therapeutic uses thereof |
| 09/10/2009 | US20090227015 hepatocellular carcinoma; osteopontin and alpha-fetoprotein |
| 09/10/2009 | US20090227014 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/10/2009 | US20090227012 Nucleotide sequences coding modified immunoglobulin for use in prevention and treatment of cancer and/or inflammatory disease |
| 09/10/2009 | US20090227002 Methods and compositions for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs |
| 09/10/2009 | US20090226999 Low-substrate-specific amino acid racemase and process for producing racemic amino acid |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226956 Runx-mediated action of nuclear receptors and utilities thereof |
| 09/10/2009 | US20090226955 Immortalized retinal pigmented epithelial cells |
| 09/10/2009 | US20090226942 Modified aerolysin and methods of use for treating lung cancer |
| 09/10/2009 | US20090226932 Novel G Protein-Coupled Receptor |
| 09/10/2009 | US20090226930 Beta cell antigen |
| 09/10/2009 | US20090226929 Titinic ion channel, compositions and methods of use |
| 09/10/2009 | US20090226918 Gene overexpressed in cancer |
| 09/10/2009 | US20090226914 Methods and products to target, capture and characterize stem cells |
| 09/10/2009 | US20090226882 Method for Identifying Fungicidally Active Compounds that are Based on Ipp Isomerases |
| 09/10/2009 | US20090226879 Protein-Free Gamete and Embryo Handling and Culture Media Products |
| 09/10/2009 | US20090226592 Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content |
| 09/10/2009 | US20090226552 Agents and methods for diagnosing osteoarthritis |
| 09/10/2009 | US20090226536 Methods and materials relating to enhanced production of dopamine neurons |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226525 Self-assembling nanoparticle drug delivery system |
| 09/10/2009 | US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/10/2009 | US20090226487 Avian embryo particulate biomass for the production of virus antigens |
| 09/10/2009 | US20090226486 N protein mutants of porcine reproductive and respiratory syndrome virus |
| 09/10/2009 | US20090226485 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 09/10/2009 | US20090226480 Streptococcus uberis adhesion molecule |
| 09/10/2009 | US20090226474 Antibodies as T cell receptor mimics, methods of production and uses thereof |
| 09/10/2009 | US20090226473 Lymphocyte surface receptor that binds caml and methods of use thereof |
| 09/10/2009 | US20090226472 Interleukin-4 receptors |
| 09/10/2009 | US20090226471 Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment |
| 09/10/2009 | US20090226470 Compositions and methods related to mRNA translational enhancer elements |
| 09/10/2009 | US20090226469 Shiga Toxoid Chimeric Proteins |
| 09/10/2009 | US20090226466 Therapeutic anti-her2 antibody fusion polypeptides |
| 09/10/2009 | US20090226465 Macrocyclic depsipeptide antibody-drug conjugates and methods |
| 09/10/2009 | US20090226464 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 09/10/2009 | US20090226457 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 09/10/2009 | US20090226456 screening methods for identifying agonists and antagonists of TNFR-6 alpha & -6 beta activity; diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders; cancer |
| 09/10/2009 | US20090226453 Sphingosine 1-phosphate antagonism |
| 09/10/2009 | US20090226451 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 09/10/2009 | US20090226450 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 09/10/2009 | US20090226449 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226448 Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor |
| 09/10/2009 | US20090226447 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 09/10/2009 | US20090226445 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/10/2009 | US20090226443 Combination therapy with c-met and egfr antagonists |
| 09/10/2009 | US20090226442 RON antibodies and uses thereof |
| 09/10/2009 | US20090226434 Afucosylated antibodies against CCR5 and their use for the treatment of inflammatory conditions |
| 09/10/2009 | US20090226429 Antibodies That Immunospecifically Bind to TRAIL Receptors |
| 09/10/2009 | US20090226421 Recombinant monovalent antibodies and methods for production thereof |
| 09/10/2009 | US20090226417 Human B7 polypeptides |
| 09/10/2009 | US20090226406 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/10/2009 | US20090226404 Methods for Generating Antigen-Specific Effector T Cells |
| 09/10/2009 | US20090226403 Olfactory and pheromones G-protein coupled receptors |
| 09/10/2009 | US20090226402 Compositions and Methods of Vascular Injury Repair |
| 09/10/2009 | US20090226401 Methods and compositions for the treatment of parkinson's disease |
| 09/10/2009 | US20090226396 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| 09/10/2009 | US20090226387 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of cellular relaxation |
| 09/10/2009 | US20090226375 MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION AND USES THEREOF |
| 09/09/2009 | EP2098595A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 09/09/2009 | EP2098591A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
| 09/09/2009 | EP2098590A1 Cell line from Rousettus as host cell for pathogen amplification |
| 09/09/2009 | EP2098589A2 Immune cell modification method and cell modification device |
| 09/09/2009 | EP2098246A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 09/09/2009 | EP2097752A2 Method for the purification of at least one target substance that is to be identified |
| 09/09/2009 | EP2097535A2 Identification and isolation of acute myeloid leukemia stem cells |
| 09/09/2009 | EP2097526A2 Expression system of nell peptide |
| 09/09/2009 | EP2097515A1 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein |
| 09/09/2009 | EP2097513A2 Preparation and use of cell-synthesized threads |
| 09/09/2009 | EP2097453A2 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 09/09/2009 | EP2097099A1 Novel compositions and uses thereof |
| 09/09/2009 | EP2097098A1 Expression of transgenic t cell receptors in lak-t cells |
| 09/09/2009 | EP2097092A2 Modulation of rhamm (cd168) for selective adipose tissue development |
| 09/09/2009 | EP2097088A2 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 09/09/2009 | EP2097066A2 Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 09/09/2009 | EP2029725A4 Hepatic stellate cell precursors and methods of isolating same |
| 09/09/2009 | EP1885382A4 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 09/09/2009 | EP1709179B1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 09/09/2009 | EP1578958B1 Method for suppressing immune system response to transplanted tissue or cells |
| 09/09/2009 | EP1548028B1 Substituted type peptides of wt1 |
| 09/09/2009 | EP1536821A4 Inhibition of t cell activation by butyrophilin 4 or b7-l1 |
| 09/09/2009 | EP1409647A4 Composite scaffolds and methods using same for generating complex tissue grafts |
| 09/09/2009 | EP1290027B1 Immunoadhesin for the prevention of rhinovirus infection |
| 09/09/2009 | EP1181372B1 Viral expression vectors for plants |
| 09/09/2009 | EP1165096B1 Use of cytidine derivatives for the treatment of leukaemia |
| 09/09/2009 | EP1102857B1 Controlling starch synthesis |
| 09/09/2009 | EP1098962B1 Diacylglycerol acyl transferase proteins |
| 09/09/2009 | EP1015488B1 Interleukin-17 receptor-like protein |
| 09/09/2009 | EP1002068B1 Mutations in the myostatin gene cause double-muscling in mammals |
| 09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/09/2009 | EP0817847B2 Il-17 receptor |
| 09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/09/2009 | CN101528915A Hemangio-colony forming cells |
| 09/09/2009 | CN101528914A Site specific incorporation of non-natural amino acids by vertebrate cells |
| 09/09/2009 | CN101525626A Expression vector containing IER5 gene, monoclonal cell line and application thereof |
| 09/09/2009 | CN101525622A Starch synthase gene promoter with seed-specific expression and application thereof |
| 09/09/2009 | CN101525605A Araboxylan degrading enzyme |
| 09/09/2009 | CN101525602A Polypeptide for preparing anti-PINK1 polyclonal antiserum and application thereof |
| 09/09/2009 | CN101525599A Enzyme relevant to synthesis of poly (hydroxybutyrate-hydroxyvalerate) and encoding gene and application thereof |
| 09/09/2009 | CN101525596A Method for obtaining stem cell by using serum of same cord blood |